FILE PHOTO: A health worker takes test tubes with plasma and blood samples after a separation process in a centrifuge during a coronavirus disease (COVID-19) vaccination study at the Research Centers of America, in Hollywood, Florida, U.S., September 24, 2020. REUTERS/Marco Bello
LONDON (Reuters) - A major non-profit health emergencies group has set up a global laboratory network to assess data from potential COVID-19 vaccines, allowing scientists and drugmakers to compare them and speed up selection of the most effective shots.
Speaking to Reuters ahead of announcing the labs involved, Melanie Saville, director of vaccine R&D at the Coalition for Epidemic Preparedness Innovations (CEPI), said the idea was to "compare apples with apples" as drugmakers race to develop an effective shot to help control the COVID-19 pandemic.
Limited time offer:
Just RM5 per month.
